Status:
COMPLETED
Reproducibility of Virtual Exercise Assessments Versus Face-to-face Exercise Testing in Adults With Cystic Fibrosis
Lead Sponsor:
Royal Brompton & Harefield NHS Foundation Trust
Collaborating Sponsors:
King's College London
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
RExA-CF is investing if results from exercise tests (the Chester Step Test and the One-Minute Sit-to-Stand test) completed face to face are comparable to results of the same tests completed via a virt...
Eligibility Criteria
Inclusion
- Diagnosis of cystic fibrosis (as confirmed by standard criteria)
- Sixteen years of age or over
- Home internet access
- Stable CF disease as judged by the medical team
- Registered with the Royal Brompton Hospital adult CF team
Exclusion
- Inability to give consent for treatment or measurement
- Current participation in another interventional study
- Current moderate haemoptysis (greater than streaking in the sputum)
- Pregnancy
- Forced expiratory volume in 1 second (FEV1) below 30% predicted
- Dependency upon oxygen therapy (with home oxygen concentrators or portable oxygen cylinders) or non-invasive ventilation (NIV)
- Current neurological or musculoskeletal injury which would prevent completion of exercise tests
- Inability to complete the second set of exercise tests within three weeks
Key Trial Info
Start Date :
May 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT06565832
Start Date
May 1 2023
End Date
August 1 2023
Last Update
August 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Brompton Hospital, Guy's and St Thomas's NHS Foundation Trust
London, United Kingdom, SW3 6NP